Estrogen-receptor antagonists are used in the therapy of estrogen-responsive diseases including breast cancer and endometrial cancer. Tamoxifen, the non-steroidal estrogen-receptor antagonist, is now the first choice of anti-hormonal treatment for advanced breast cancer. In spite of its effectiveness, the long-term use of tamoxifen frequently results in tumor resistance to itself and its relate...
